Praj Industries has released its financial results for the first quarter of Fiscal Year 2027 (Q1-FY27). The company reported a consolidated Operating Income of ₹7,158 Mn, up 11.8% YoY. Consolidated Net Profit saw a significant increase of 118.9% YoY to ₹116 Mn, with Diluted EPS at ₹0.63. The Bioenergy segment continues to be the largest revenue contributor at 66%.
Praj Industries Reports Strong Q1 FY27 Performance
Praj Industries Limited announced its unaudited financial results for the quarter ended June 30, 2026 (Q1-FY27). The company demonstrated robust growth across key financial metrics, highlighting its expanding market presence and operational efficiency.
Consolidated Financial Highlights (Q1-FY27)
The consolidated financial performance for Q1-FY27 showcased a notable increase in revenue and profitability:
- Operating Income: Stood at INR 7,158 Mn, marking a substantial year-over-year growth of 11.8%.
- Operating EBITDA: Recorded at INR 300 Mn.
- EBITDA Margins: At 4.19%.
- Net Profit: Surged by 118.9% YoY to INR 116 Mn.
- PAT Margins: Reached 1.62%.
- Diluted EPS: Improved to INR 0.63, a significant jump of 117.2% YoY.
Standalone Financial Performance (Q1-FY27)
On a standalone basis, Praj Industries also reported positive trends:
- Operating Income: INR 5,392 Mn, up 5.7% YoY.
- Operating EBITDA: INR 204 Mn, a decrease of (27.1)% YoY.
- EBITDA Margins: 3.78%.
- Net Profit: Increased by 27.0% YoY to INR 254 Mn.
- PAT Margins: 4.71%.
- Diluted EPS: INR 1.38, up 26.6% YoY.
Revenue Breakup and Order Book
The segmental revenue for Q1-FY27 was primarily driven by the Bioenergy segment, accounting for 66% of the total. Engineering contributed 22%, and HiPurity made up 12%. Geographically, domestic revenue represented 75%, with exports at 25%.
The company’s order book remains strong, with an Order Intake of INR 10,000 Mn in Q1-FY27, predominantly from the Bioenergy segment (62%). The Order Backlog at the end of Q1-FY27 stood at a substantial INR 45,890 Mn, with Bioenergy making up 77% of it.
Operational and Industry Insights
Key operational highlights from Q1-FY27 include:
- 1G: Received orders for India’s first commercial demo plant for Bio-IBA and a greenfield Grain to Ethanol plant in Brazil.
- CBG: The Union Cabinet’s approval of the GOBARdhan scheme is expected to accelerate CBG production.
- Engineering and PHS: Signed a framework agreement for hyperscale data center infrastructure projects (approx. INR 500 crore opportunity) and received an order for ultra-pure water and ZLD solutions from a semiconductor player.
The presentation also highlighted the inauguration of the Dr. Pramod Chaudhari Centre of Excellence for Advanced Bioeconomy at Savitribai Phule Pune University (SPPU), emphasizing the company’s commitment to research and development.
Source: BSE
